EDGAR Filing Documents for 0001123292-23-000122

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001123292-23-000122

Filing Date

2023-10-10

Accepted

2023-10-10 07:40:48

Documents

Effectiveness Date

2023-10-10

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	10349
	Complete submission text file	0001123292-23-000122.txt		11500

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5

Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)